Professional medical & aesthetic supply For eligible business and healthcare customers
Contact Sales ↗
Home/Our Products/Xolair 150 mg
Xolair 150 mg

Xolair 150 mg

Capacity: 150 mg · 1 syringe
Category: Specialty Care, Immunology
Availability: Available on request
More product details ›
Quantity:
Request a Quote

Xolair 150 mg (Omalizumab 150 mg) by Novartis.

Indications: Severe persistent allergic asthma, chronic spontaneous urticaria, chronic rhinosinusitis with nasal polyps and IgE-mediated food allergy (per market).

Administration: Subcutaneous injection every 2–4 weeks; dose by IgE level and body weight.

Storage: Store in a refrigerator at 2–8 °C. Do not freeze. Keep in the outer carton to protect from light.

Prescription-only medicine (POM). Supplied against a valid prescription / to licensed healthcare professionals only.

ManufacturerNovartis
Active ingredientOmalizumab 150 mg — anti-IgE monoclonal antibody.
Strength & pack1 pre-filled syringe/pen (or vial of powder).
FormSolution for injection
StorageStore in a refrigerator at 2–8 °C. Do not freeze. Keep in the outer carton to protect from light.
Regulatory statusPrescription-only medicine (POM). Supplied against a valid prescription / to licensed healthcare professionals only.